Please login to the form below
Clementia Pharmaceuticals
This page shows the latest Clementia Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Ipsen buys rare disease group Clementia in $1.3bn deal
Will acquire lead multiple rare disease candidate palovarotene. Ipsen is set to pay out a total of $1.3bn to buy Clementia Pharmaceuticals in a move that will significantly boost its ... The acquisition of Clementia Pharmaceuticals accelerates the
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Events Executive
-
DOE
- Account Manager – Healthcare advertising
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
Subscribe to our email news alerts
- Envision Pharma Group relocates to support expansion
- A roadmap to the successful treatment of Alzheimer’s disease
- Novartis eyes potential new indication for Cosentyx
- Acceleron scraps rare muscular dystrophy drug
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- New data backs GeNeuro’s MS drug after Servier exit
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- A roadmap to the successful treatment of Alzheimer’s disease
- Building on past research to learn more about the disease and how to treat it...
- Article: Like, Like, Like: Harnessing the power of social media insights
- ...
- Its Know Your Numbers week
- Do you know yours?...
Quick links
Infographics
